Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer
Cancer. 2011;117(13):2830-2832 
43 oral A retrospective comparison of the use of androgen deprivation among low and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
Radiotherapy and Oncology. 2004;71:S21
Comparison of radical prostatectomy and external beam radiotherapy in high-risk prostate cancer
Radiation Oncology Journal. 2021;39(3):231-238
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
Urologic Oncology: Seminars and Original Investigations. 2004;22(4):378
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer: Why EBRT+ADT remains the gold standard
Reports of Practical Oncology & Radiotherapy. 2013;18:S102
21 oral External beam irradiation (XRT) is inferior to high dose rate brachytherapy in combination with XRT or radical prostatectomy in treating localised prostate cancer (PC)
Radiotherapy and Oncology. 2003;66:S9
The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study
Urologia Internationalis. 2021;106(1):11-19
PV-0629: External beam RT with brachytherapy vs prostatectomy in treatment of high-risk prostate cancer
Radiotherapy and Oncology. 2018;127:S334-S335
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy
Urologic Oncology: Seminars and Original Investigations. 2005;23(4):305
Re: Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9–10 Prostate Cancer
European Urology. 2018;74(4):526